Uniwersytecki Dzieciecy Szpital Kliniczny Im. L. Zamenhofa W Bialymstoku samodzielny publiczny zakład opieki zdrowotnej

At Uniwersytecki Dzieciecy Szpital Kliniczny Im. L. Zamenhofa W Bialymstoku samodzielny publiczny zakład opieki zdrowotnej, clinical research in the Neoplasms area focuses on serious childhood cancers, especially acute lymphoblastic leukemia in infants. The trials are aimed at improving treatment outcomes and long-term survival for very young patients.

• Studying infant acute lymphoblastic leukemia to improve event-free survival and strengthen treatment results
• Evaluating new approaches for newly diagnosed KMT2A-rearranged leukemia in pediatric oncology
• Supporting research on better cancer care for infants through more effective therapy strategies

This work reflects the site’s active role in pediatric oncology, with a clear emphasis on testing therapies that may offer better disease control and future outcomes for children.

The department also conducts research in Hormonal Diseases, with a strong focus on idiopathic growth hormone deficiency in children. These trials are designed to assess the long-term safety of treatment and help clarify how well children respond over time.

• Following children with idiopathic growth hormone deficiency to better understand treatment safety and durability
• Exploring endocrine care options that may support healthier growth in pediatric patients
• Contributing to evidence on the long-term use of therapies for growth hormone deficiency

Research in this area combines pediatric endocrinology and patient safety, helping clinicians refine care for children living with growth-related hormonal disorders.